Oncology Central

Advancing treatment options for medullary thyroid cancer: an interview with Jonathan Wadsley

To mark Rare Disease Day we recently spoke with Jonathan Wadsley (Weston Park Hospital, Sheffield, UK) about recent advancements in care for medullary thyroid cancer.

Could you tell us what the current licensed treatment options for medullary thyroid cancer are?

One of the things that’s important to understand with medullary thyroid cancer is it can be a very indolent condition.  Meaning that the cancer could have spread to the bones and the liver for example but it can still be quite a stable disease. Therefore

To view restricted content, please:

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.